Helicobacter pylori eradication treatment and the risk of Barrett's esophagus and esophageal adenocarcinoma

Eva Doorakkers,Jesper Lagergren,Giola Santoni,Lars Engstrand,Nele Brusselaers

DOI: https://doi.org/10.1111/hel.12688

2020-03-16

Helicobacter

Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p><i>Helicobacter pylori</i> (<i>H. pylori</i>) is associated with lower risks of Barrett's esophagus and esophageal adenocarcinoma, but whether <i>H. pylori</i> eradication increases the risk of these conditions is unknown. This study aimed to test the hypothesis that <i>H. pylori</i> eradication leads to gradually increased risks of Barrett's esophagus and esophageal adenocarcinoma over time, while esophageal squamous cell carcinoma was assessed for comparison reasons. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Material and Methods</h3><p>This Swedish nationwide, population‐based cohort study in 2005‐2012 used data from the Swedish Prescribed Drug Registry to assess eradication treatment for <i>H. pylori</i>. Barrett's esophagus was identified from the Swedish Patient Registry, and esophageal adenocarcinoma and squamous cell carcinoma from the Swedish Cancer Registry. Standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) were calculated by dividing the observed risk in the <i>H. pylori</i> eradication treatment cohort by the expected risk derived from the Swedish population of the same age, sex, and calendar period. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The cohort included 81 919 patients having had eradication treatment. For Barrett's esophagus (n = 178), the overall SIR was increased (SIR 3.67, 95% CI 3.15‐4.25), but the SIRs slightly decreased over time after eradication treatment. For esophageal adenocarcinoma (n = 11), the overall SIR was 1.26 (95% CI 0.62‐2.26), and the SIRs did not increase over time. The SIRs of esophageal squamous cell carcinoma (n = 10) were not influenced by eradication treatment.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>This study did not provide any evidence of an increasing risk of Barrett's esophagus or esophageal adenocarcinoma (or esophageal squamous cell carcinoma) over time after eradication treatment for <i>H. pylori</i>. </p></section>

gastroenterology & hepatology,microbiology